Lichen planus responding to efalizumab

被引：18

作者：

Boehm, Markus ^{[1
]}

Luger, Thomas A. ^{[1
]}

机构：

[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2007年 / 56卷 / 05期

关键词：

D O I：

10.1016/j.jaad.2006.10.957

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 [皮肤病与性病学];

摘要：

Lichen planus (LP) is a common inflammatory skin disorder of unknown origin. When generalized and relapsing, treatment of LP can be a challenge. We present a patient with widespread and relapsing generalized LP who was treated with efalizumab for 3 months. Both pruritus and the skin lesions responded promptly to this biologic. In accordance with the previously reported efficacy in oral erosive LP, efalizumab may be a promising novel future treatment option for patients with Cutaneous LP.

引用

页码：S92 / S93

页数：2

共 9 条

[1]

DIFFERENTIAL EXPRESSION OF ADHESION MOLECULES ON INFILTRATING CELLS IN INFLAMMATORY DERMATOSES [J].

BOEHNCKE, WH ;

KELLNER, I ;

KONTER, U ;

STERRY, W .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (06) :907-913

[2]

Oral erosive lichen planus treated with efalizumab [J].

Cheng, A ;

Mann, C .

ARCHIVES OF DERMATOLOGY, 2006, 142 (06) :680-682

[3]

Gaylor Minh-Ly N, 2004, J Drugs Dermatol, V3, P77

[4]

Clinical considerations of efalizumab therapy in patients with psoriasis [J].

Hamilton, TK .

SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2005, 24 (01) :19-27

[5]

How T cells use LFA-1 to attach and migrate [J].

Hogg, N ;

Smith, A ;

McDowall, A ;

Giles, K ;

Stanley, P ;

Laschinger, M ;

Henderson, R .

IMMUNOLOGY LETTERS, 2004, 92 (1-2) :51-54

[6]

LOEWS MA, 2005, BMC DERMATOL, V18, P1

[7]

Leukocyte function-associated antigen-1: Structure, function and application prospects [J].

Ma, XY ;

Zheng, WY ;

Wang, TW .

PROTEIN AND PEPTIDE LETTERS, 2006, 13 (04) :397-400

[8]

Ohta Yukinori, 1992, Journal of Dermatology (Tokyo), V19, P414

[9]

Anti-inflammatory - Efalizumab: a review of events reported during clinical trials and side effects [J].

Scheinfeld, Noah .

EXPERT OPINION ON DRUG SAFETY, 2006, 5 (02) :197-209

← 1 →